RxSight (RXST) Total Current Liabilities (2020 - 2026)

RxSight's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $27.4 million for Q1 2026.

• Quarterly Total Current Liabilities rose 20.38% year-over-year to $27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.4 million (up 20.38% YoY) and the FY2025 annual result came in at $26.3 million, up 1.46% from the prior year.
• Total Current Liabilities was $27.4 million for Q1 2026 at RxSight, up from $26.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $27.4 million in Q1 2026 and bottomed at $10.7 million in Q1 2022.
• A 5-year average of $19.6 million and a median of $19.6 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities surged 78.38% — and 2025, when it fell 1.53%.
• RxSight's Total Current Liabilities stood at $17.2 million in 2022, then increased by 21.27% to $20.9 million in 2023, then gained by 23.79% to $25.9 million in 2024, then advanced by 1.46% to $26.3 million in 2025, then gained by 4.28% to $27.4 million in 2026.
• Business Quant data shows RXST's Total Current Liabilities at $27.4 million in Q1 2026, $26.3 million in Q4 2025, and $22.3 million in Q3 2025.